Biovie (BIVI) Prepaid Assets (2014 - 2026)
Biovie (BIVI) posted Prepaid Assets of $1.6 million for Q1 2026, up 52.27% sequentially from $1.1 million in Q4 2025, and up 182.17% YoY from $569527.0 in Q1 2025.
Biovie (BIVI) Prepaid Assets (2014 - 2026) Analysis & Trends
Biovie has reported Prepaid Assets for 11 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Prepaid Assets rose 182.17% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 182.17% YoY) and the FY2025 annual result came in at $1.0 million, up 413.67% from the prior year.
- Prepaid Assets improved to $1.6 million in Q1 2026 per BIVI's latest filing, from $1.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.6 million in Q1 2026 and troughed at $102526.0 in Q2 2023.
- A 5-year average of $541942.0 and a median of $284967.0 in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets sank 91.76% in 2024, then surged 584.43% in 2025.
- Over 5 years, Prepaid Assets stood at $241282.0 in 2022, then soared by 38.83% to $334963.0 in 2023, then declined by 17.65% to $275835.0 in 2024, then soared by 282.61% to $1.1 million in 2025, then soared by 52.27% to $1.6 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.6 million, $1.1 million, and $873884.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.51 Mn |
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 873,884.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 569,527.00 |
| Dec 31, 2024 | 275,835.00 |
| Sep 30, 2024 | 127,680.00 |
| Jun 30, 2024 | 204,392.00 |
| Mar 31, 2024 | 189,582.00 |
| Dec 31, 2023 | 334,963.00 |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 102,526.00 |
| Mar 31, 2023 | 249,790.00 |
| Dec 31, 2022 | 241,282.00 |
| Sep 30, 2022 | 359,123.00 |
| Jun 30, 2022 | 137,879.00 |
| Mar 31, 2022 | 284,967.00 |
| Dec 31, 2021 | 154,868.00 |
| Sep 30, 2021 | 105,923.00 |